FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's mycophenolate mofetil as an original application; it is used to prevent organ transplant rejection in kidney, liver, and heart transplants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)